Filing Details
- Accession Number:
- 0001181431-12-040006
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-06 16:08:17
- Reporting Period:
- 2012-07-05
- Filing Date:
- 2012-07-06
- Accepted Time:
- 2012-07-06 16:08:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1329010 | Laurent Chardonnet | Experimental Station Route 141 &Amp; Henry Clay Road Wilmington DE 19880 | No | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-07-05 | 35,700 | $7.09 | 38,734 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-07-05 | 5,586 | $25.10 | 33,148 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-07-05 | 27,300 | $25.11 | 5,848 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-07-05 | 2,214 | $25.12 | 3,634 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-07-05 | 600 | $25.13 | 3,034 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-07-05 | 35,700 | $0.00 | 35,700 | $7.09 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2014-02-11 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- Beginning February 12, 2007, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.